Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

Similar articles for PubMed (Select 15555967)

1.

Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation.

Lang JE, Esserman LJ, Ewing CA, Rugo HS, Lane KT, Leong SP, Hwang ES.

J Am Coll Surg. 2004 Dec;199(6):856-62.

PMID:
15555967
2.

A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important.

Jones JL, Zabicki K, Christian RL, Gadd MA, Hughes KS, Lesnikoski BA, Rhei E, Specht MC, Dominguez FJ, Smith BL.

Am J Surg. 2005 Oct;190(4):517-20.

PMID:
16164912
3.

Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation.

Newman EA, Sabel MS, Nees AV, Schott A, Diehl KM, Cimmino VM, Chang AE, Kleer C, Hayes DF, Newman LA.

Ann Surg Oncol. 2007 Oct;14(10):2946-52. Epub 2007 May 19.

PMID:
17514407
4.

Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients.

Lee S, Kim EY, Kang SH, Kim SW, Kim SK, Kang KW, Kwon Y, Shin KH, Kang HS, Ro J, Lee ES.

Breast Cancer Res Treat. 2007 May;102(3):283-8. Epub 2006 Oct 25.

PMID:
17063280
5.

Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.

Gimbergues P, Abrial C, Durando X, Le Bouedec G, Cachin F, Penault-Llorca F, Mouret-Reynier MA, Kwiatkowski F, Maublant J, Tchirkov A, Dauplat J.

Ann Surg Oncol. 2008 May;15(5):1316-21. doi: 10.1245/s10434-007-9759-z. Epub 2008 Mar 1.

PMID:
18311507
6.

Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?

Marrazzo A, Taormina P, Gebbiab V, David M, Riili I, Lo Gerfo D, Casà L, Noto A.

Chir Ital. 2007 Sep-Oct;59(5):693-9.

PMID:
18019642
7.

Sentinel node biopsy before neoadjuvant chemotherapy spares breast cancer patients axillary lymph node dissection.

van Rijk MC, Nieweg OE, Rutgers EJ, Oldenburg HS, Olmos RV, Hoefnagel CA, Kroon BB.

Ann Surg Oncol. 2006 Apr;13(4):475-9. Epub 2006 Feb 17.

PMID:
16485148
8.
9.

Thin-section CT evaluation and pathologic correlation of therapeutic effect of neoadjuvant chemotherapy for axillary lymph nodes of clinically node-positive breast cancer patients.

Ogawa Y, Nishioka A, Nishigawa T, Kubota K, Kariya S, Yoshida S, Tanaka Y, Moriki T, Tochika N.

Oncol Rep. 2003 Jul-Aug;10(4):985-9.

PMID:
12792757
11.

Sentinel lymphadenectomy for the staging of clinical axillary node-negative breast cancer before neoadjuvant chemotherapy.

Menard JP, Extra JM, Jacquemier J, Buttarelli M, Lambaudie E, Bannier M, Brenot Rossi I, Houvenaeghel G.

Eur J Surg Oncol. 2009 Sep;35(9):916-20. doi: 10.1016/j.ejso.2008.11.002. Epub 2009 Jan 20.

PMID:
19157769
12.

Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer.

Julian TB, Dusi D, Wolmark N.

Am J Surg. 2002 Oct;184(4):315-7.

PMID:
12383891
13.

Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer.

Stearns V, Ewing CA, Slack R, Penannen MF, Hayes DF, Tsangaris TN.

Ann Surg Oncol. 2002 Apr;9(3):235-42.

PMID:
11923129
14.

Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy.

Kinoshita T, Takasugi M, Iwamoto E, Akashi-Tanaka S, Fukutomi T, Terui S.

Am J Surg. 2006 Feb;191(2):225-9.

PMID:
16442950
15.

Neoadjuvant chemotherapy in the treatment of stage II and III breast cancer.

Singletary SE.

Am J Surg. 2001 Oct;182(4):341-6.

PMID:
11720667
16.

Can breast MRI predict axillary lymph node metastasis in women undergoing neoadjuvant chemotherapy.

Javid S, Segara D, Lotfi P, Raza S, Golshan M.

Ann Surg Oncol. 2010 Jul;17(7):1841-6. doi: 10.1245/s10434-010-0934-2. Epub 2010 Feb 9.

PMID:
20143266
17.

Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.

Shen J, Gilcrease MZ, Babiera GV, Ross MI, Meric-Bernstam F, Feig BW, Kuerer HM, Francis A, Ames FC, Hunt KK.

Cancer. 2007 Apr 1;109(7):1255-63.

18.

Sentinel node biopsy in breast cancer patients treated with neoadjuvant chemotherapy.

Tanaka Y, Maeda H, Ogawa Y, Nishioka A, Itoh S, Kubota K, Ue H, Nakatani K, Sasaguri S.

Oncol Rep. 2006 Apr;15(4):927-31.

PMID:
16525681
19.

Comprehensive axillary evaluation in neoadjuvant chemotherapy patients with ultrasonography and sentinel lymph node biopsy.

Khan A, Sabel MS, Nees A, Diehl KM, Cimmino VM, Kleer CG, Schott AF, Hayes DF, Chang AE, Newman LA.

Ann Surg Oncol. 2005 Sep;12(9):697-704. Epub 2005 Aug 4.

PMID:
16079956
20.

Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer.

Cox CE, Cox JM, White LB, Stowell NG, Clark JD, Allred N, Meyers M, Dupont E, Furman B, Minton S.

Ann Surg Oncol. 2006 Apr;13(4):483-90. Epub 2006 Mar 7.

PMID:
16523361
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk